Severe left ventricular dysfunction secondary to primary pulmonary hypertension: bridging therapy with bosentan before lung transplantation.

Détails

ID Serval
serval:BIB_58BD502750AF
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Titre
Severe left ventricular dysfunction secondary to primary pulmonary hypertension: bridging therapy with bosentan before lung transplantation.
Périodique
Journal of Heart and Lung Transplantation
Auteur⸱e⸱s
Brauchlin A.E., Soccal P.M., Rochat T., Spiliopoulos A., Nicod L.P., Trindade P.T.
ISSN
1053-2498[print], 1053-2498[linking]
Statut éditorial
Publié
Date de publication
2005
Volume
24
Numéro
6
Pages
777-780
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Résumé
When right ventricular failure develops secondary to primary pulmonary hypertension, right-left ventricular interaction may lead to severe impairment of left ventricular function. In such cases, many experts favor combined heart-lung transplantation by fear that the left ventricle may not recover after transplantation of the lungs alone. We report a case of primary pulmonary hypertension with severely diminished right and left ventricular function. The patient was rendered amenable to isolated pulmonary transplantation with the endothelin-receptor antagonist bosentan. The medication improved right and left ventricular function to the point that heart transplantation no longer appeared necessary. After double-lung transplantation the patient's cardiac function made a full recovery. This approach might be particularly welcome considering both the current donor organ shortage and the limited number of surgical teams with expertise in heart-lung transplantation.
Mots-clé
Adult, Antihypertensive Agents/therapeutic use, Combined Modality Therapy, Humans, Hypertension, Pulmonary/complications, Hypertension, Pulmonary/therapy, Lung Transplantation, Male, Severity of Illness Index, Sulfonamides/therapeutic use, Ventricular Dysfunction, Left/etiology, Ventricular Dysfunction, Right/etiology
Pubmed
Web of science
Création de la notice
19/02/2010 20:16
Dernière modification de la notice
20/08/2019 15:12
Données d'usage